Literature DB >> 7481201

Biostatistical methodology in clinical trials--a European guideline.

J A Lewis1, D R Jones, J Röhmel.   

Abstract

Mesh：

Year:  1995        PMID： 7481201     DOI： 10.1002/sim.4780141506

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  6 in total

1.  Applying a medical budget system to biostatistics clinics.

Authors:  Toshio Makie
Journal:  J Med Syst       Date:  2004-10       Impact factor: 4.460

Review 2.  Statistical considerations in infant nutrition trials.

Authors:  S M Gore
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

3.  Trials to assess equivalence: the importance of rigorous methods.

Authors:  B Jones; P Jarvis; J A Lewis; A F Ebbutt
Journal:  BMJ       Date:  1996-07-06

4.  Noninferiority and equivalence designs: issues and implications for mental health research.

Authors:  Carolyn J Greene; Leslie A Morland; Valerie L Durkalski; B Christopher Frueh
Journal:  J Trauma Stress       Date:  2008-10

5.  A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.

Authors:  Alexander Chuchalin; Eszter Csiszér; Kàlmàn Gyurkovics; Maria Trawińska Bartnicka; Dorota Sands; Nikolai Kapranov; Guido Varoli; Pier Alessandro Monici Preti; Henryk Mazurek
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Authors:  Gerard Lenoir; Yuriy Genadievich Antypkin; Angelo Miano; Paolo Moretti; Maurizio Zanda; Guido Varoli; Pier Alessandro Monici Preti; Nikolay Leonidovich Aryayev
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.